TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis. An Randomised, Crossover Pilot Study of AZLI Plus Intravenous Colistin® Versus Standard Dual Intravenous Therapy
Brief Summary: This study evaluates the role of AZLI in the treatment of acute pulmonary exacerbations of CF. For consecutive exacerbations patients will receive AZLI + IV Colistin, or two IV anti-pseudomonals.


Options:
A: Arm Label: Observational; Type: N/A; Interventions: N/A
B: Arm Label: Tobramycin 300 mg for 28 days; Type: EXPERIMENTAL; Interventions: Drug: Tobramycin solution for inhalation 300 mg | Arm Label: Tobramycin 300 mg for 56 days; Type: EXPERIMENTAL; Interventions: Drug: Tobramycin solution for inhalation 300 mg | Intervention Type: DRUG; Name: Tobramycin solution for inhalation 300 mg; Assigned to Arm(s): Tobramycin 300 mg for 28 days, Tobramycin 300 mg for 56 days
C: Arm Label: AZLI then Standard Care; Type: EXPERIMENTAL; Interventions: Drug: Aztreonam, Drug: Standard Care | Arm Label: Standard Care then AZLI; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aztreonam, Drug: Standard Care | Intervention Type: DRUG; Name: Aztreonam; Assigned to Arm(s): AZLI then Standard Care, Standard Care then AZLI | Intervention Type: DRUG; Name: Standard Care; Assigned to Arm(s): AZLI then Standard Care, Standard Care then AZLI
D: Arm Label: Placebo (pooled two times a day [BID]/three times a day [TID]); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo two times a day (BID)/three times a day (TID) | Arm Label: AZLI (pooled two times a day [BID]/three times a day [TID]); Type: EXPERIMENTAL; Interventions: Drug: AZLI 75 mg two times a day (BID)/three times a day (TID) | Intervention Type: DRUG; Name: AZLI 75 mg two times a day (BID)/three times a day (TID); Assigned to Arm(s): AZLI (pooled two times a day [BID]/three times a day [TID]) | Intervention Type: DRUG; Name: Placebo two times a day (BID)/three times a day (TID); Assigned to Arm(s): Placebo (pooled two times a day [BID]/three times a day [TID])

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis. An Randomised, Crossover Pilot Study of AZLI Plus Intravenous Colistin® Versus Standard Dual Intravenous Therapy
Brief Summary: This study evaluates the role of AZLI in the treatment of acute pulmonary exacerbations of CF. For consecutive exacerbations patients will receive AZLI + IV Colistin, or two IV anti-pseudomonals.


Options:
A: Arm Label: AZLI then Standard Care; Type: EXPERIMENTAL; Interventions: Drug: Aztreonam, Drug: Standard Care | Arm Label: Standard Care then AZLI; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aztreonam, Drug: Standard Care | Intervention Type: DRUG; Name: Aztreonam; Assigned to Arm(s): AZLI then Standard Care, Standard Care then AZLI | Intervention Type: DRUG; Name: Standard Care; Assigned to Arm(s): AZLI then Standard Care, Standard Care then AZLI
B: Arm Label: AZLI 75 mg 3 times a day (TID); Type: EXPERIMENTAL; Interventions: Drug: Aztreonam for Inhalation Solution (AZLI) | Arm Label: TIS 300 mg 2 times a day (BID); Type: ACTIVE_COMPARATOR; Interventions: Drug: Tobramycin Inhalation Solution (TIS) | Intervention Type: DRUG; Name: Aztreonam for Inhalation Solution (AZLI); Assigned to Arm(s): AZLI 75 mg 3 times a day (TID) | Intervention Type: DRUG; Name: Tobramycin Inhalation Solution (TIS); Assigned to Arm(s): TIS 300 mg 2 times a day (BID)
C: Arm Label: 32.50 mg Ciprofloxacin DPI (BAYQ3939); Type: EXPERIMENTAL; Interventions: Drug: Ciprofloxacin (Cipro Inhale, BAYQ3939) | Arm Label: 48.75 mg Ciprofloxacin DPI (BAYQ3939); Type: EXPERIMENTAL; Interventions: Drug: Ciprofloxacin (Cipro Inhale, BAYQ3939) | Arm Label: Matching Placebo for 32.50 mg; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Matching Placebo for 48.75 mg; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ciprofloxacin (Cipro Inhale, BAYQ3939); Assigned to Arm(s): 32.50 mg Ciprofloxacin DPI (BAYQ3939) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Matching Placebo for 32.50 mg | Intervention Type: DRUG; Name: Ciprofloxacin (Cipro Inhale, BAYQ3939); Assigned to Arm(s): 48.75 mg Ciprofloxacin DPI (BAYQ3939) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Matching Placebo for 48.75 mg
D: Arm Label: Arikayce™; Type: EXPERIMENTAL; Interventions: Drug: Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer. | Arm Label: TOBI®; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tobramycin inhalation solution using a PARI LC® Plus nebulizer. | Intervention Type: DRUG; Name: Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer.; Assigned to Arm(s): Arikayce™ | Intervention Type: DRUG; Name: Tobramycin inhalation solution using a PARI LC® Plus nebulizer.; Assigned to Arm(s): TOBI®

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis. An Randomised, Crossover Pilot Study of AZLI Plus Intravenous Colistin® Versus Standard Dual Intravenous Therapy
Brief Summary: This study evaluates the role of AZLI in the treatment of acute pulmonary exacerbations of CF. For consecutive exacerbations patients will receive AZLI + IV Colistin, or two IV anti-pseudomonals.


Options:
A: Arm Label: Aeroquin; Type: EXPERIMENTAL; Interventions: Drug: MP-376 (Levofloxacin Solution for Inhalation) | Arm Label: TIS; Type: ACTIVE_COMPARATOR; Interventions: Drug: TIS (Tobramycin Inhalation Solution) | Intervention Type: DRUG; Name: MP-376 (Levofloxacin Solution for Inhalation); Assigned to Arm(s): Aeroquin | Intervention Type: DRUG; Name: TIS (Tobramycin Inhalation Solution); Assigned to Arm(s): TIS
B: Arm Label: CF patients with pulmonary exacerbations; Type: N/A; Interventions: N/A
C: Arm Label: Observational; Type: N/A; Interventions: N/A
D: Arm Label: AZLI then Standard Care; Type: EXPERIMENTAL; Interventions: Drug: Aztreonam, Drug: Standard Care | Arm Label: Standard Care then AZLI; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aztreonam, Drug: Standard Care | Intervention Type: DRUG; Name: Aztreonam; Assigned to Arm(s): AZLI then Standard Care, Standard Care then AZLI | Intervention Type: DRUG; Name: Standard Care; Assigned to Arm(s): AZLI then Standard Care, Standard Care then AZLI

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lifestyle Intervention for Breast Cancer Survivors
Brief Summary: The purpose of this study is to examine the effects of exercise program on health-related physical fitness and biomarkers among breast cancer survivors.


Options:
A: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supervised Exercise Training Program | Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Supervised Exercise Training Program; Assigned to Arm(s): 2
B: Arm Label: Exercise Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity counseling | Arm Label: Contact Control; Type: PLACEBO_COMPARATOR; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physical activity counseling; Assigned to Arm(s): Exercise Counseling
C: Arm Label: Exercise in breast cancer survivors; Type: EXPERIMENTAL; Interventions: Behavioral: Combined aerobic and strength exercise training | Arm Label: No exercise in breast cancer survivors; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise in healthy subjects; Type: SHAM_COMPARATOR; Interventions: Behavioral: Combined aerobic and strength exercise training | Intervention Type: BEHAVIORAL; Name: Combined aerobic and strength exercise training; Assigned to Arm(s): Exercise in breast cancer survivors, Exercise in healthy subjects
D: Arm Label: Exercise and whole grain rye; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise, Behavioral: Whole grain rye, Behavioral: Recommendations | Arm Label: No prescriptions; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Recommendations | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise and whole grain rye | Intervention Type: BEHAVIORAL; Name: Whole grain rye; Assigned to Arm(s): Exercise and whole grain rye | Intervention Type: BEHAVIORAL; Name: Recommendations; Assigned to Arm(s): Exercise and whole grain rye, No prescriptions

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lifestyle Intervention for Breast Cancer Survivors
Brief Summary: The purpose of this study is to examine the effects of exercise program on health-related physical fitness and biomarkers among breast cancer survivors.


Options:
A: Arm Label: Group 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Resistance and aerobic training | Arm Label: Group 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Aerobic training | Arm Label: Group 3; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard supportive care | Intervention Type: OTHER; Name: Resistance and aerobic training; Assigned to Arm(s): Group 1 | Intervention Type: OTHER; Name: Aerobic training; Assigned to Arm(s): Group 2 | Intervention Type: OTHER; Name: Standard supportive care; Assigned to Arm(s): Group 3
B: Arm Label: Exercise in breast cancer survivors; Type: EXPERIMENTAL; Interventions: Behavioral: Combined aerobic and strength exercise training | Arm Label: No exercise in breast cancer survivors; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise in healthy subjects; Type: SHAM_COMPARATOR; Interventions: Behavioral: Combined aerobic and strength exercise training | Intervention Type: BEHAVIORAL; Name: Combined aerobic and strength exercise training; Assigned to Arm(s): Exercise in breast cancer survivors, Exercise in healthy subjects
C: Arm Label: weight loss intervention; Type: EXPERIMENTAL; Interventions: Behavioral: weight loss intervention | Arm Label: Weight Loss plus Resistance Training; Type: EXPERIMENTAL; Interventions: Behavioral: Weight Loss | Arm Label: Comparator; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Weight Loss | Intervention Type: BEHAVIORAL; Name: weight loss intervention; Assigned to Arm(s): weight loss intervention | Intervention Type: BEHAVIORAL; Name: Weight Loss; Assigned to Arm(s): Weight Loss plus Resistance Training | Intervention Type: BEHAVIORAL; Name: Weight Loss; Assigned to Arm(s): Comparator
D: Arm Label: Wait-list control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: behavioral dietary and exercise intervention | Intervention Type: BEHAVIORAL; Name: behavioral dietary and exercise intervention; Assigned to Arm(s): Lifestyle counseling

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Partnership for Mental Health Development in Sub-Saharan Africa: COllaborative Shared Care to IMprove Psychosis Outcome
Brief Summary: COSIMPO is a randomised controlled trial in which a collaborative shared care for psychosis implemented by complementary alternative providers (traditional and faith healers) and conventional primary health care providers (PHCP) is compared with care as usual in which no formal collaboration takes place between the two groups of health providers. COSIMPO is therefore a test of a complex task sharing approach for the care of patients with severe mental disorders.


Options:
A: Arm Label: Computerized CBT + Internet Support Group; Type: EXPERIMENTAL; Interventions: Behavioral: CCBT+ISG/Collaborative Care | Arm Label: Computerized CBT Alone; Type: EXPERIMENTAL; Interventions: Behavioral: CCBT/Collaborative Care | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: CCBT+ISG/Collaborative Care; Assigned to Arm(s): Computerized CBT + Internet Support Group | Intervention Type: BEHAVIORAL; Name: CCBT/Collaborative Care; Assigned to Arm(s): Computerized CBT Alone
B: Arm Label: Collaborative shared care; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative shared care | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Collaborative shared care | Intervention Type: BEHAVIORAL; Name: Collaborative shared care; Assigned to Arm(s): Collaborative shared care, Usual care
C: Arm Label: Supported Employment Only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supported Employment | Arm Label: Thinking Skills for Work; Type: EXPERIMENTAL; Interventions: Behavioral: Thinking Skills for Work Program | Intervention Type: BEHAVIORAL; Name: Thinking Skills for Work Program; Assigned to Arm(s): Thinking Skills for Work | Intervention Type: BEHAVIORAL; Name: Supported Employment; Assigned to Arm(s): Supported Employment Only
D: Intervention Type: DRUG; Name: lithium; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: valproate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: bupropion; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: paroxetine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: lamotrigine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: risperidone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: inositol; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: tranylcypromine; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Family-focused Therapy; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Interpersonal and Social Rhythms Therapy; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Partnership for Mental Health Development in Sub-Saharan Africa: COllaborative Shared Care to IMprove Psychosis Outcome
Brief Summary: COSIMPO is a randomised controlled trial in which a collaborative shared care for psychosis implemented by complementary alternative providers (traditional and faith healers) and conventional primary health care providers (PHCP) is compared with care as usual in which no formal collaboration takes place between the two groups of health providers. COSIMPO is therefore a test of a complex task sharing approach for the care of patients with severe mental disorders.


Options:
A: Arm Label: Philani Intervention Program; Type: EXPERIMENTAL; Interventions: Behavioral: Philani Intervention Program | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Philani Intervention Program; Assigned to Arm(s): Philani Intervention Program
B: Arm Label: ARM 1: Component-Based Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Common Elements Treatment Approach | Arm Label: ARM 2: Community Group Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Narrative Community Group Therapy | Arm Label: ARM 3: Standby group; Type: OTHER; Interventions: Other: Standby group | Intervention Type: BEHAVIORAL; Name: Common Elements Treatment Approach; Assigned to Arm(s): ARM 1: Component-Based Intervention | Intervention Type: BEHAVIORAL; Name: Narrative Community Group Therapy; Assigned to Arm(s): ARM 2: Community Group Therapy | Intervention Type: OTHER; Name: Standby group; Assigned to Arm(s): ARM 3: Standby group
C: Arm Label: Cognitive Behavioral Therapy Intervention for Anxiety; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy Intervention for Anxiety | Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy Intervention for Anxiety; Assigned to Arm(s): Cognitive Behavioral Therapy Intervention for Anxiety
D: Arm Label: Collaborative shared care; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative shared care | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Collaborative shared care | Intervention Type: BEHAVIORAL; Name: Collaborative shared care; Assigned to Arm(s): Collaborative shared care, Usual care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Behavioral Interventions for Improvement of Adherence at Exercise-based Cardiac Rehabilitation (ECRA)
Brief Summary: The purpose of this study is to investigate the effects of an extended behavioral intervention in exercise-based CR for improvement of physical capacity, adherence, psychological and physiological parameters, compared with usual care.


Options:
A: Arm Label: A; Type: OTHER; Interventions: Other: A: Home-Based exercise after Cardiac Rehabilitation | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: A: Home-Based exercise after Cardiac Rehabilitation; Assigned to Arm(s): A
B: Arm Label: Extended behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Extended behavioral intervention | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Extended behavioral intervention; Assigned to Arm(s): Extended behavioral intervention
C: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Usual care + letters; Type: EXPERIMENTAL; Interventions: Behavioral: Usual care + letters | Arm Label: Usual care + letters + automated calls; Type: EXPERIMENTAL; Interventions: Behavioral: Usual care + letters + automated calls | Intervention Type: BEHAVIORAL; Name: Usual care + letters; Assigned to Arm(s): Usual care + letters | Intervention Type: BEHAVIORAL; Name: Usual care + letters + automated calls; Assigned to Arm(s): Usual care + letters + automated calls
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Rehabilitation in institution | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Rehabilitation at home, Behavioral: Out-patient rehabilitation at the hospital | Intervention Type: BEHAVIORAL; Name: Rehabilitation in institution; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Rehabilitation at home; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Out-patient rehabilitation at the hospital; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Behavioral Interventions for Improvement of Adherence at Exercise-based Cardiac Rehabilitation (ECRA)
Brief Summary: The purpose of this study is to investigate the effects of an extended behavioral intervention in exercise-based CR for improvement of physical capacity, adherence, psychological and physiological parameters, compared with usual care.


Options:
A: Arm Label: UC; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: vCRP; Type: EXPERIMENTAL; Interventions: Behavioral: vCRP | Intervention Type: BEHAVIORAL; Name: vCRP; Assigned to Arm(s): vCRP
B: Arm Label: Extended behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Extended behavioral intervention | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Extended behavioral intervention; Assigned to Arm(s): Extended behavioral intervention
C: Arm Label: Cardiac Rehabilitation Peer Mentorship; Type: EXPERIMENTAL; Interventions: Behavioral: Cardiac Rehabilitation Peer Mentorship | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cardiac Rehabilitation Peer Mentorship; Assigned to Arm(s): Cardiac Rehabilitation Peer Mentorship
D: Arm Label: PATCH Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: PATCH intervention | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: PATCH intervention; Assigned to Arm(s): PATCH Intervention | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Consumption of Dairy Products on Glycemic Control, Body Weight and Cardiovascular Risk Factors in Patients With Type 2 Diabetes: A Randomized Controlled Clinical Study
Brief Summary: This is a randomized prospective clinical study in patients with type 2 diabetes to evaluate the effect of dairy products with full or low fat on glycemic control and cardio-metabolic risk factors in comparison to a regular diet.


Options:
A: Arm Label: Full fat dairy group; Type: EXPERIMENTAL; Interventions: Other: Full fat dairy | Arm Label: Low fat dairy group; Type: EXPERIMENTAL; Interventions: Other: Low fat dairy | Arm Label: Control group; Type: OTHER; Interventions: Other: Control | Intervention Type: OTHER; Name: Full fat dairy; Assigned to Arm(s): Full fat dairy group | Intervention Type: OTHER; Name: Low fat dairy; Assigned to Arm(s): Low fat dairy group | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control group
B: Arm Label: DIPI: Danish national dietary guidelines; Type: ACTIVE_COMPARATOR; Interventions: Other: DIPI | Arm Label: DIPI: Specific IHD dietary guideline; Type: ACTIVE_COMPARATOR; Interventions: Other: DIPI | Arm Label: Normal dietary habits; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: DIPI; Assigned to Arm(s): DIPI: Danish national dietary guidelines, DIPI: Specific IHD dietary guideline
C: Arm Label: low fat hypocaloric diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: dietary intervention | Arm Label: Low carbohydrate hypocaloric diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: dietary intervention | Intervention Type: BEHAVIORAL; Name: dietary intervention; Assigned to Arm(s): Low carbohydrate hypocaloric diet, low fat hypocaloric diet
D: Arm Label: High MUFA diet; Type: EXPERIMENTAL; Interventions: Other: High-MUFA diet | Arm Label: High CHO diet; Type: ACTIVE_COMPARATOR; Interventions: Other: High-CHO diet | Intervention Type: OTHER; Name: High-MUFA diet; Assigned to Arm(s): High MUFA diet | Intervention Type: OTHER; Name: High-CHO diet; Assigned to Arm(s): High CHO diet

Answer: A